The vector of anti-HER2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human HER2. The T cells are genetically modified through transduction with a retroviral vector expressing HER2-specific T cell receptor. And the vector product was designed for the treatment of breast cancers.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C130||Lenti-Her2 T cell receptor (A3) Viral Particle|
|CAR-T-2-L337-CZ||Anti-ErbB2 scFv h(b2c-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC724||Lenti-HER2 CAR (scFv-CD28-41BB-CD3ζ, 6D) Viral Particle|
|VP-CAR-LC757||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5G98A) Viral Particle|
|CAR-T-2-L337-4G||Anti-ErbB2 scFv h(CD4-FcεRIγ) CART, pCDCAR1|
|CAR-NK-3-M331-2XZ||Anti-ErbB2 scFv h(CD28-OX40-CD3ζ) CARNK, pCDCAR1|
|TCR-L050||Human anti-ERBB2 (ErbB2 369–377) T Cell Receptor, pMSGV|
|VP-TCR-C127||Lenti-HER2 T cell receptor (HER2-1) Viral Particle|
|TCR-L050Z||Human anti-HER2 (aa368-377) T cell receptor, pCDTCR1|
|CAR-MZ033||Anti-ErbB2 (C6.5G98A) h(CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved